Identification of P-glycoprotein mutations causing a loss of steroid recognition and transport

被引:16
作者
Vo, QD [1 ]
Gruol, DJ [1 ]
机构
[1] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.274.29.20318
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoproteins transport a wide variety of hydrophobic compounds out of cells, While the diversity of transported molecules suggests a mechanism involving broad specificity, there is evidence of significant discrimination within given classes of molecules. One example of this behavior is transport of corticosteroids by the murine mdr1 P-glycoprotein, The presence of hydroxyl groups, associated with specific steroid carbon atoms, regulates the ability of corticosteroids to be transported. This specificity is demonstrated here by experiments measuring the ability of steroids to inhibit drug transport. The results indicate that a keto oxygen associated with the 3- and 20-carbon atoms, as well as a 17-carbon hydroxyl group, each acts to enhance steroidal P-glycoprotein inhibitory activity. Moreover, inhibitory steroids can be used for directed selection of variant cells, expressing mutated P-glycoproteins with a severely impaired ability to transport dexamethasone. The five mutations, reported here, are located within transmembrane domains 4-6, proximal to the cytoplasmic interface. The altered P-glycoproteins exhibit reduced capacity to be inhibited by specific steroids, suggesting decreased capacity to bind these molecules avidly. Studies comparing the relative inhibitory activity of a series of steroids indicate that these mutations alter recognition of the 17 alpha-hydroxyl group and the 20-keto oxygen atom.
引用
收藏
页码:20318 / 20327
页数:10
相关论文
共 54 条
[1]   Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region [J].
Bakos, E ;
Klein, I ;
Welker, E ;
Szabo, K ;
Muller, M ;
Sarkadi, B ;
Varadi, A .
BIOCHEMICAL JOURNAL, 1997, 323 :777-783
[2]   Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells [J].
Barnes, KM ;
Dickstein, B ;
Cutler, GB ;
Fojo, T ;
Bates, SE .
BIOCHEMISTRY, 1996, 35 (15) :4820-4827
[3]   Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity [J].
Beaudet, L ;
Urbatsch, IL ;
Gros, P .
BIOCHEMISTRY, 1998, 37 (25) :9073-9082
[4]   EXPRESSION OF AN MDR GENE IS ASSOCIATED WITH A NEW FORM OF RESISTANCE TO DEXAMETHASONE-INDUCED APOPTOSIS [J].
BOURGEOIS, S ;
GRUOL, DJ ;
NEWBY, RF ;
RAJAH, FM .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (07) :840-851
[5]  
BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483
[6]  
BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020
[7]   Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins [J].
Chen, G ;
Duran, GE ;
Steger, KA ;
Lacayo, NJ ;
Jaffrezou, JP ;
Dumontet, C ;
Sikic, BI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5974-5982
[8]   AN ALTERED PATTERN OF CROSS-RESISTANCE IN MULTIDRUG-RESISTANT HUMAN-CELLS RESULTS FROM SPONTANEOUS MUTATIONS IN THE MDR1 (P-GLYCOPROTEIN) GENE [J].
CHOI, K ;
CHEN, C ;
KRIEGLER, M ;
RONINSON, IB .
CELL, 1988, 53 (04) :519-529
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]  
CURRIER SJ, 1992, J BIOL CHEM, V267, P25153